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Abstract
 Introduction—This study prospectively examined whether HIV leads to elevated risk for 
intimate partner violence (IPV) for women, and how this risk varies depending on HIV status 
disclosure to a partner.
 Methods—We ran a series of logistic regression models using data from 1092 pregnant and 
postpartum women enrolled in an RCT in Durban, South Africa, The first model assessed whether 
baseline HIV-status predicted 14-week postpartum physical IPV, controlling for baseline physical 
IPV, disclosure to partner, demographic and study covariates. Model 2 added the interaction 
between HIV status and disclosure.
 Results—HIV was not associated with 14-week physical IPV in the main effects model 
adjusted odds ratio (AOR) 1.34, 95% CI: .88 - 2.05). However, there was a statistically significant 
positive interaction between HIV and disclosure, (AOR 0.22, 95% CI: .05-.96). Among women 
who disclosed their HIV status, HIV was not significantly associated with 14-week IPV (AOR 
1.12; 95% CI 0.71-1.89). However, among women who had not disclosed, the odds of reporting 
IPV at 14 weeks was 5.15 times higher for HIV-positive women as compared to HIV-negative 
women (95% CI: 1.25-21.00).
 Discussion—While we established that HIV does not increase incidence of IPV for all HIV-
positive women, we found an elevated risk of IPV among the HIV-positive women who chose not 
to disclose their status to their partner. Non-disclosure is likely a marker for other problematic 
aspects of the relationship, and counselors should either find alternative safe options for disclosure 
or support women’s decisions not to disclose.
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 INTRODUCTION
Numerous studies have documented an association between intimate partner violence (IPV) 
victimization and HIV infection among women across a number of different settings (for 
reviews see, (Kouyoumdjian, Findlay, Schwandt, & Calzavara, 2013; Y. Li et al., 2014). The 
predominant theoretical perspective driving this research posits that IPV leads to HIV 
infection either directly, through forced sex with an infected parther, and/or indirectly by, for 
example, limiting women’s ability to negotiate safe sex (Jewkes, Dunkle, Nduna, & Shai, 
2010; S. Maman, Campbell, Sweat, & Gielen, 2000). However, scholars have also 
acknowledged the possibility for a reverse causal pathway wherein HIV infection may lead 
to increased risk of experiencing IPV (Campbell et al., 2008; Durevall & Lindskog, 2015; 
Hatcher et al., 2014). In particular, qualitative research suggests that women who are 
diagnosed with HIV may experience violence and other negative social outcomes as a result 
of sharing their HIV positive status with their partner (Gielen, O’Campo, Faden, & Eke, 
1997; Hatcher et al., 2014; Medley, Garcia-Moreno, McGill, & Maman, 2004; Mulrenan, 
Colombini, Howard, Kikuvi, & Mayhew, 2015; Siemieniuk et al., 2013). Further, women 
who are diagnosed with HIV may experience financial, emotional, physiological stress, 
depression, and reduced social support that may contribute to relationship conflict and 
increase vulnerability to IPV (Hand, Phillips, & Dudgeon, 2006). If diagnosis with HIV is a 
risk factor for IPV, it suggests the importance of developing IPV-prevention programs for 
HIV-infected women. Yet, to date, nearly all of the studies examining relations between IPV 
and HIV have been cross-sectional (Kouyoumdjian, Findlay, et al., 2013; Y. Li et al., 2014), 
precluding the ability to establish temporality of associations, and the few longitudinal 
studies that have been conducted have examined whether IPV predicts HIV rather than vice-
versa (e.g., (Jewkes et al., 2010), (Kouyoumdjian, Calzavara, et al., 2013). A prospective 
study from Kenya reported that among HIV-positive pregnant women in their cohort the 
odds of experiencing physical, psychological or financial abuse from a partner two weeks 
after diagnosis was significantly higher than among HIV-negative women, when controlling 
for disclosure. (Kiarie et al., 2006). The authors in this study did not examine the interactive 
effect of disclosure and diagnosis on women’s experiences with IPV.
The current study was designed to address the gaps in the literature using a sample of 
pregnant South African women. Two primary aims guided the study. The first aim examined 
the main effects of HIV status, diagnosed during pregnancy on physical IPV victimization at 
14 weeks postpartum. We hypothesized that HIV-positive women would be at increased risk 
for postpartum IPV as compared to HIV-negative women. The second aim investigated the 
possibility that HIV-disclosure moderated the effect of HIV-status on IPV. Previous research 
suggests two competing hypotheses concerning the direction of this interaction. On the one 
hand, as noted above, findings from some qualitative research suggest that disclosure of 
HIV-positive status may trigger violence. This suggests that HIV may be more strongly 
related to IPV among women who disclose their status than among women who do not 
disclose their status. That is, among women who disclose their HIV-status to their partner, 
disclosure of an HIV-positive diagnosis may be more likely to spark conflict and violence 
than disclosure of an HIV-negative diagnosis; among women who do not disclose their HIV-
status, HIV-infection may be unrelated to IPV.
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On the other hand, qualitative research also suggests that women may choose not to disclose 
that they are HIV-positive to their partner precisely because they fear negative reactions and 
abuse. Non-disclosure of HIV-positive status may thus be a marker indicating involvement in 
an unhealthy violence-prone relationship. This line of reasoning suggests that HIV may be 
more strongly related to IPV among women who do not disclose than among women who do 
disclose their status. That is, among women who do not disclose, HIV-status may be 
positively related to IPV because HIV-positive non-disclosers are more likely to be in 
unhealthy relationships than HIV-negative non-disclosers. In contrast, among women who 
do disclose, HIV may be unrelated to IPV; HIV-positive women who choose to disclose their 
HIV-status rightfully anticipate that disclosure will not precipitate violence and thus are at 
no greater risk for IPV than HIV-negative women who disclose their status.
 Methods
 Study design and sample
Data for the proposed analyses were collected as part of a randomized control trial, the 
South Africa HIV/AIDS Antenatal Posttest Support (SAHAPS) study, which was designed 
to evaluate the efficacy of an enhanced counseling and support intervention for HIV-positive 
and HIV-negative women during pregnancy and the postpartum period. Participants were 
women who attended antenatal care at a public primary health clinic in Umlazi township in 
the province of KwaZulu Natal (KZN). KZN has the highest antenatal prevalence of HIV 
infection and highest infant mortality in South Africa (Coovadia, Jewkes, Barron, Sanders, 
& McIntyre, 2009; Karim et al., 2011). Pregnant women who presented to the clinic for their 
first antenatal visit were eligible for screening. Inclusion criteria were: (1) at least 18 years 
old, (2) had never tested for HIV or had tested negative for HIV at least 3 months prior to 
recruitment, (3) attending first antenatal visit when HIV testing was offered; (4) had a 
primary intimate partner for at least the past 6 months, (5) planned to live in Durban for at 
least the next year, (6) planned to bring their infant to the clinic for immunization visits, (7) 
able to communicate in English or Zulu, and; (8) did not need care for a high risk pregnancy 
since such patients needed to be referred to a tertiary public health facility. Women who 
consented to participate completed a Computer Assisted Personal Interview (CAPI) in Zulu 
or in English and were tested for HIV and STIs at baseline (1st antenatal visit) and again at 
14 weeks postpartum. Women were not aware of their HIV diagnosis prior to completion of 
their baseline survey. The interviews were conducted by locally trained data collectors who 
were fluent in English and Zulu. We screened 3333 women, and determined that 1636 of 
these women met our eligibility criteria. The most common reasons women were not eligible 
included that they had previously tested positive for HIV, and they were not planning on 
being in Durban for the next year. Of the 1636, who met the eligibility criteria, 136 declined 
to participate and 20 were not tested for HIV as part of our study. We enrolled 1480 women 
in the trial. Following completion of the baseline interview 733, women were randomized to 
receive the enhanced counseling intervention (intervention) and 747 were randomized to 
receive the standard counseling and testing (control).
Among the 1480 women who were enrolled in the study at baseline and eligible for follow-
up; 79% (1147) of these women were retained at the 14 week postpartum follow-up. Data 
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for this study come from 1092 women who completed interviews at both at baseline and 14 
week follow-up and were not missing data on key variables at follow up. At baseline, 
participants were, on average, 25.57 years old (range 18-45); 36.90% were HIV-positive; 
30.40% had experienced physical IPV in their current relationship prior to or during the 
current pregnancy, 63.19% reported having had at least one prior pregnancy, and 79.30% 
reported the current pregnancy was unintended. More details on the study sample and 
protocol, including intervention and HIV/STI testing procedures are included in prior 
publications (S. Maman, Moodley, Groves, & Smith, 2007; S. Maman et al., 2014). The 
research was approved by the institutional review board at the University of North Carolina 
and the University of KwaZuluNatal.
 Measures
 Physical IPV—A modified version of the World Health Organization (WHO) Violence 
Against Women instrument was used to measure physical IPV (Garcia-Moreno, Jansen, 
Ellsberg, Heise, & Watts, 2006). This instrument has six questions on physical violence that 
a woman has experienced with her current partner and has been used in numerous South 
African studies (e.g., (Jewkes et al., 2010); (K. L. Dunkle et al., 2004). A sample item is, 
“how many times has your current partner pushed or shoved you?” In this study, the stem of 
the questions was modified to reflect the specific reference period the participants were 
being asked about (before or during pregnancy, from delivery to 14 weeks postpartum). Each 
item had five response categories that ranged from never to more than ten times. Responses 
to the six items were summed and then, due to skew in the distribution of the IPV variable at 
follow-up, dichotomized to create two binary variables: (1) Baseline Physical IPV assessed 
the presence or absence of any physical IPV perpetrated by the woman’s partner prior to 
and/or during pregnancy and; (2) Follow-up Physical IPV assessed the presence of absence 
of any physical IPV by the woman’s partner between delivery and 14-weeks postpartum.
 HIV-status and disclosure—HIV status and HIV disclosure to partner were 
dichotomized to create binary variables for analysis.
 Demographic and study covariates—Participants reported their age, education, and 
length of their relationship at the baseline visit, which occurred during their first antenatal 
care visit. Following previous research in South Africa, we created a measure of 
socioeconomic status by using principal components analysis to derive a linear index from a 
series of asset ownership indicators and then categorized participants as belong to the 
poorest 40%, middle 40% or wealthiest 20% on the asset index scale (BERG & Louw, 2004; 
Blaauw & Penn-Kekana, 2003; Filmer & Pritchett, 2001; Gyekye & Akinboade, 2003). 
Pregnancy characteristics included gestational age at first antenatal visit (no. of weeks), 
parity (never, 1 time, 2 or more times) and whether the current pregnancy was intended (yes/
no). We also controlled for the amount of time between the completion of the baseline 
survey and the completion of the 14 week follow up survey (no. of weeks). Sensitivity 
analysis indicated there were no significant differences in findings across study arms, so 
study allocation arm was not included as a covariate.
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 Statistical Analysis—Analyses for the current manuscript proceeded in several phases. 
First, we conducted bivariate analysis to examine differences in baseline and follow-up IPV, 
HIV− disclosure, and covariates by HIV status. Next a series of logistic regression models 
were run to examine study hypotheses regarding the prospective association between HIV 
and follow-up physical IPV. The first model (main effects) assessed whether baseline HIV-
status predicted physical IPV at follow-up, controlling for baseline physical IPV, disclosure 
to partner, as well as all of the demographic and study covariates described above. Model 2 
(full) added the interaction between HIV-status and disclosure. All statistical analyses were 
performed using SAS software, version 9.3(SAS Institute Inc., 2011).
 RESULTS
 Descriptive results
HIV positive women in the sample were older on average (26.41 years vs 25.07, p<.0001), 
of lower socioeconomic status (42.68% vs. 34.40%, p=0.006), and less likely to have 
completed high school (49.63% vs. 36.43% p<.0001). HIV-positive women had also been in 
their relationships with their primary partners for a shorter amount of time (3.80 years vs 
4.76 years, p<.0001). The HIV-negative women were more likely to be pregnant for the first 
time (40.64% vs. 30.27%, p=.001), and more likely to have disclosed to their partner 
(94.63% vs. 76.43%, p<.0001). There were no significant differences in reports of physical 
IPV at baseline (32.01% vs. 29.46%) and 14 weeks postpartum (14.14% vs 11.47%) among 
the HIV-positive as compared to the HIV-negative women in the sample. See Table 1.
 Multivariate results
Contrary to expectations, HIV was not associated with physical IPV at follow-up in the main 
effects model (AOR 1.34, 95% CI: .88 - 2.05). However, there was a statistically significant 
positive interaction between HIV and disclosure, (AOR 0.22, 95% CI: .05-.96). Following 
standard recommendations, post-hoc analyses were conducted to determine the simple 
slopes for the effects of HIV status on physical IPV within each level of the moderator 
(disclosure). Among women who disclosed their HIV status, HIV was not significantly 
associated with IPV at follow-up (AOR 1.12; 95% CI 0.71-1.89). However, among women 
who had not disclosed, the odds of reporting IPV at 14 weeks was 5.15 times higher for HIV 
positive women as compared to HIV-negative women (95% CI: 1.25-21.20). These findings 
are depicted graphically in Figure 1 which presents the model-implied predicted probability 
of IPV at 14 weeks postpartum for HIV positive and HIV negative women who did and did 
not disclose their HIV-status.
 DISCUSSION
We found that HIV diagnosis during pregnancy prospectively predicted postpartum IPV 
among women who reported that they had not disclosed their HIV status to their partner at 
the time of follow up. Specifically, HIV-positive women who had not disclosed were 
approximately five times more likely to report experiencing IPV at 14 weeks postpartum 
when compared to HIV-negative women who had not disclosed. This finding is consistent 
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with the notion that non-disclosure of HIV-positive status may be a marker indicating 
involvement in an unhealthy relationship with a violence-prone partner.
On the other hand, HIV was not predictive of IPV among women who did disclose their HIV 
status; HIV-positive women in our study who disclosed their status to their partners were not 
at increased risk for IPV when compared to HIV-negative women who disclosed. Prior 
studies, primarily qualitative, have documented some IPV and other negative social 
outcomes among HIV-infected women who disclose their status to their partners, however 
our findings do not support these prior studies (Gielen, McDonnell, Burke, & O’Campo, 
2000; Gielen et al., 1997; Murray et al., 2006; Strebel et al., 2006). Another prospective 
study examined pregnant women’s experiences with IPV following diagnosis in Kenya 
(Kiarie et al., 2006). Investigators found a greater odds of reporting IPV among HIV-positive 
women as compared to HIV-negative women, however, the investigators did not examine 
whether the association between diagnosis and IPV differed by disclosure. They controlled 
for disclosure in their analysis, making it difficult to compare their results to our findings. In 
addition, the follow-up assessment in the Kenya study occurred 2 weeks after diagnosis, and 
not during the postpartum period for women, and the measurement of violence in this study 
included psychological and financial abuse, further limiting the comparability to our 
findings.
There is a larger body of research that has explored how IPV may increase women’s risk for 
HIV. Evidence from these studies have been mixed. Among the many cross-sectional 
studies, more than half from sub-Saharan Africa reported null findings, while others reported 
significant associations(Dude, 2011; Kristin L Dunkle et al., 2004; Ketchen, Armistead, & 
Cook, 2009; Suzanne Maman et al., 2002; Mattson, Settergren, & Sabatier, 2009; Ntaganira, 
Muula, Siziya, Stoskopf, & Rudatsikira, 2009; Pettifor, Measham, Rees, & Padian, 2004; Sa 
& Larsen, 2008; Van der Straten et al., 1998). There have been four longitudinal studies 
from sub-Saharan Africa and two of these studies found that there was a significant 
association between IPV and incident HIV, and two did not find this association (Jewkes et 
al., 2010; Kouyoumdjian, Calzavara, et al., 2013; Were et al., 2011; Zablotska et al., 2009). 
Results of a meta-analysis found significant associations in cohort and cross-sectional 
studies, but not in case-control studies (Ying Li et al., 2014). Our findings suggest that 
researchers need to consider not just whether the association exists, but whether this 
relationship matters more for certain groups of vulnerable women.
Our findings suggest that as part of the HIV post-test counseling session, counselors should 
assess women’s disclosure plans. For HIV-positive women who feel comfortable disclosing, 
counselors should encourage them to do so since it is likely that they will not be at any 
greater risk for IPV than HIV-negative women who disclose. It is certainly possible that 
some HIV-positive women who disclose their status will experience negative reactions from 
partners, and counselors should be prepared to provide support and resources to these 
women.
Almost a quarter (23.6%) of HIV-infected women in our sample had not shared their HIV 
test result with their partner by 14-weeks postpartum. This rate of non-disclosure is within 
the range of non-disclosure, 14% to 83.3%, that was reported, in a review of studies among 
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women (Medley et al., 2004). The fact that there continues to be a substantial number of 
HIV-positive women who opt not to share their diagnosis with their partners, and these 
women are at greater risk for experiencing IPV, has important implications for practice. 
Health care providers should be aware that non-disclosure of HIV status is a marker that 
may indicate involvement in an unhealthy violence-prone relationship. Providers should 
assess the potential for violence and refer women to counseling or other support services. 
More generally, the principle of do no harm must continue to inform our counseling and 
support for women. While disclosure of HIV status is an important public health goal to 
increase awareness of risk for HIV, this has to be pursued carefully in the case of women 
who may be at risk for IPV. Before we address disclosure, it is important to address 
women’s exposure to violence in relationships, and offer women services and support to 
address the violence. If we focus on disclosure, without assessing risk of violence, we run 
the risk of putting these women in physical danger if we push women to disclose when it is 
not safe to do so. We need to explore and test alternative ways to support safe disclosure for 
women, and accept the fact that disclosure may not always be in the best interest of women 
and therefore should not be supported until women can insure their own safety. Couples HIV 
counseling and testing is one approach that may help facilitate the safe disclosure of HIV 
status. In the couples counseling approach, a counselor is present with the couple as they 
share their HIV results with each other. The counselor is trained to facilitate the disclosure 
and mediate conflict between partners. In this model, counselors can also facilitate access to 
other care and support resources for the couple, enhancing the support that they have to cope 
with the diagnosis. Couples counseling may not be appropriate in relationships where 
women are exposed to severe violence from a partner(O’Leary, 2008).
Our prospective design and the enrollment of both HIV-positive and HIV-negative women in 
our trial are major strengths of this study that enabled us to assess the temporal relationship 
between HIV diagnosis and IPV victimization, and to assess whether this relationship varied 
for those who did or did not disclose their HIV status. Other strengths of the trial include the 
large sample size, and our retention of nearly 80% of women in the trial, which is high in 
this urban, highly mobile setting. The study was not without limitations. As is the case with 
all studies that rely on self-reported data, there is the possibility that women may have 
misreported their experiences with IPV, and whether they disclosed their status to their 
partner. We included text that was designed to normalize the reporting of IPV for women 
prior to asking them to report their own experiences, which may have helped women feel 
more comfortable reporting these sensitive experiences.
 CONCLUSION
These findings provide new insight on the relationship between HIV status, disclosure of 
HIV status to partners and subsequent experiences with IPV. The results from this cohort of 
women indicate that HIV-positive women who disclose their status are not significantly 
more likely to experience IPV than HIV-negative women who disclose and therefore that 
HIV-positive women who feel prepared to disclose should be supported in this decision 
during HIV counseling and testing. The fact that nearly a quarter of all HIV-positive women 
reported that they had not shared their HIV test results with their partner, and that these 
women are at greater risk for experiencing IPV postpartum remains a concern. Among those 
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women who had not disclosed, HIV-positive women were significantly more likely to report 
violence in the postpartum period than HIV-negative women. For women who do not feel 
comfortable disclosing their HIV status to their partners, counselors should be prepared to 
assess their risk for violence and provide services and support to them to address this risk. 
Disclosure may not be in these women’s best interest and should not be encouraged until 
women can insure their safety.
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Figure 1. 
Interaction of HIV status and disclosure on 14 week IPV
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